Top Stories:
Home » Education

Education

Renzo Galanello Fellowship Programme 2017

OUR SPECIALIST TEAM: Prof John Porter, Supervisor Dr Perla Eleftheriou, Coordinator and many other valuable colleagues. FUNDING: A stipend of $2000 USD/month for each successful candidate, which intends to cover the successful candidate’s accommodation, daily transportation and basic living expenses. Any expenses above this amount will be the responsibility of the ...

Read More »

Renzo Galanello Fellowship Programme 2016

We feel extremely privileged and delighted to provide the official completion report of the last TIF – Renzo Galanello Fellowship which took place between 3rd of October – 30th of November 2016 through the Joint Red Cell Unit of the Haematology Department of the University College London Hospital (UCLH) in ...

Read More »

NTDTs

Non-Transfusion Dependent Thalassaemias (NTDTs) is a term used to label patients who do not need regular blood transfusions for survival but may need occasional or even frequent transfusions for defined periods of time.

Read More »

Thalassaemia cure

At present, thalassemia can be cured in some children by bone marrow transplant.  Gene therapy is being studied as a potential cure for some patients.

Read More »

Clinical Trials and updates

Clinical trials are experiments or observations carried out in clinical research, designed to answer specific questions about new treatments such as novel vaccines, drugs etc. for further study and comparison.

Read More »

Alpha thalassaemia

This section is dedicated to alpha (α-) thalassaemia. THE MAJOR ALPHA (α-) THALASSAEMIAS ARE: HbH disease α-thalassaemia Hydrops Foetalis (=Hb Bart’s Hydrops Foetalis) Many diseases in humans are caused by abnormalities in the blood and these are categorized according to the component of the blood which is affected: white cell ...

Read More »

Beta Thalassaemia

What is beta thalassaemia This section is dedicated to beta (β-) thalassaemia syndromes of which β-thalassaemia major, also known as Mediterranean anaemia or Cooley’s Anaemia, is the clinically most severe one. THE MAJOR BETA (β-) THALASSAEMIA SYNDROMES ARE: β-thalassaemia major β-thalassaemia intermedia HbE/β-thalassaemia Other rare thalassaemias Many diseases in humans ...

Read More »

Sickle cell disease

SCD is caused by a haemoglobin defect, known as Haemoglobin S. In SCD, the bone marrow cannot produce enough healthy red cells. The red cells produced look like sickles, are not flexible and can stick on vessels’ walls causing blood clots and preventing oxygen from reaching the body tissues.

Read More »

TIF Academy

The Thalassaemia International Federation (TIF) has developed an internationally-recognised educational programme, with the objective to continuously educate health professionals, patients and their families, the community at large and policy-makers. TIF offers a full-fledged multimodal educational programme including the following:

Read More »